Clinical trial

Efficiency Control of Fluticasone/Formoterol K-haler (Medium Strength) vs ICS/LABA (High Strength) in Asthma Patients

NCT04271839

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

COMBINATION_PRODUCT · Unmapped registry intervention fluticasone/formoterol k-haler (medium strength) Find medicine records · Find other trials using this name

COMBINATION_PRODUCT · Unmapped registry intervention Standard of care (ICs/LABA high strength) Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Efficiency Control of Fluticasone/Formoterol K-haler (Medium Strength) vs ICS/LABA (High Strength) in Asthma Patients

Design: INTERVENTIONAL · Status: WITHDRAWN · Phase: PHASE4

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusWITHDRAWN

Study typeINTERVENTIONAL

Start date2020-06-11

PhasePHASE4

Conditions

Persistent Asthmaunresolved

Interventions

fluticasone/formoterol k-haler (medium strength)COMBINATION_PRODUCT

Standard of care (ICs/LABA high strength)COMBINATION_PRODUCT

Sponsors & collaborators

Mundipharma Pharmaceuticals S.L.lead sponsor

Alpha Bioresearch S.L.collaborator

Dynamic Solutionscollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04271839 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.